151 related articles for article (PubMed ID: 21712409)
1. Tumor immunology: basic and clinical advances.
Beatty PL; Cascio S; Lutz E
Cancer Res; 2011 Jul; 71(13):4338-43. PubMed ID: 21712409
[TBL] [Abstract][Full Text] [Related]
2. Tumor immunology: multidisciplinary science driving basic and clinical advances.
Keenan BP; Jaffee EM; Armstrong TD
Cancer Immunol Res; 2013 Jul; 1(1):16-23. PubMed ID: 24409447
[TBL] [Abstract][Full Text] [Related]
3. Cancer immunotherapy: harnessing the immune system to battle cancer.
Yang Y
J Clin Invest; 2015 Sep; 125(9):3335-7. PubMed ID: 26325031
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in cancer immunology and immunology-based anticancer therapies.
Kumar S; Saini RV; Mahindroo N
Biomed Pharmacother; 2017 Dec; 96():1491-1500. PubMed ID: 29198747
[TBL] [Abstract][Full Text] [Related]
5. Workshop on challenges, insights, and future directions for mouse and humanized models in cancer immunology and immunotherapy: a report from the associated programs of the 2016 annual meeting for the Society for Immunotherapy of cancer.
Zloza A; Karolina Palucka A; Coussens LM; Gotwals PJ; Headley MB; Jaffee EM; Lund AW; Sharpe AH; Sznol M; Wainwright DA; Wong KK; Bosenberg MW
J Immunother Cancer; 2017 Sep; 5(1):77. PubMed ID: 28923102
[TBL] [Abstract][Full Text] [Related]
6. Immune based therapies in cancer.
Krüger C; Greten TF; Korangy F
Histol Histopathol; 2007 Jun; 22(6):687-96. PubMed ID: 17357098
[TBL] [Abstract][Full Text] [Related]
7. Ethical considerations of cellular immunotherapy for cancer.
Ren SS; Deng JW; Hong M; Ren YL; Fu HJ; Liu YN; Chen Z
J Zhejiang Univ Sci B; 2019 Jan.; 20(1):23-31. PubMed ID: 30614227
[TBL] [Abstract][Full Text] [Related]
8. Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?
Fry TJ; Lankester AC
Pediatr Clin North Am; 2008 Feb; 55(1):147-67, xi. PubMed ID: 18242319
[TBL] [Abstract][Full Text] [Related]
9. Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology Keystone Symposia Meeting Summary.
Gubin MM
Cancer Immunol Res; 2017 Jun; 5(6):434-438. PubMed ID: 28576922
[TBL] [Abstract][Full Text] [Related]
10. [Development of novel immunotherapy targeting cancer immune evasion].
Tamada K
Gan To Kagaku Ryoho; 2014 Sep; 41(9):1062-5. PubMed ID: 25248888
[TBL] [Abstract][Full Text] [Related]
11. The 14th European Immunology Meeting--EFIS 2000. 23-27 September 2000, Poznañ, Poland.
Wysocki PJ; Nawrocki S; Mackiewicz A
Expert Opin Biol Ther; 2001 Jan; 1(1):135-40. PubMed ID: 11727543
[TBL] [Abstract][Full Text] [Related]
12. The path to reactivation of antitumor immunity and checkpoint immunotherapy.
Kim HJ; Cantor H
Cancer Immunol Res; 2014 Oct; 2(10):926-36. PubMed ID: 25281320
[TBL] [Abstract][Full Text] [Related]
13. Translating Science into Survival: Report on the Inaugural International Cancer Immunotherapy Conference.
Hubbard-Lucey VM; Tontonoz MJ
Cancer Immunol Res; 2016 Jan; 4(1):3-11. PubMed ID: 27119139
[TBL] [Abstract][Full Text] [Related]
14. Recent advances and current challenges in tumor immunology and immunotherapy.
Guinn BA; Kasahara N; Farzaneh F; Habib NA; Norris JS; Deisseroth AB
Mol Ther; 2007 Jun; 15(6):1065-71. PubMed ID: 17375068
[TBL] [Abstract][Full Text] [Related]
15. Principles of immunology and its nuances in the central nervous system.
Dunn GP; Okada H
Neuro Oncol; 2015 Nov; 17 Suppl 7(Suppl 7):vii3-vii8. PubMed ID: 26516224
[TBL] [Abstract][Full Text] [Related]
16. FOCIS goes south: advances in translational and clinical immunology.
Kalergis AM; Anegon I; González PA
Immunotherapy; 2017 Sep; 9(10):789-792. PubMed ID: 28877630
[TBL] [Abstract][Full Text] [Related]
17. Conference scene: Immune signatures in the tumor and beyond.
Kandalaft LE; Kalos M; Melief CJ; Speiser DE; Coukos G
Immunotherapy; 2012 Aug; 4(8):761-72. PubMed ID: 22947003
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.
Wang H; Franco F; Ho PC
Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles for tumor immunotherapy.
Zang X; Zhao X; Hu H; Qiao M; Deng Y; Chen D
Eur J Pharm Biopharm; 2017 Jun; 115():243-256. PubMed ID: 28323111
[TBL] [Abstract][Full Text] [Related]
20. Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy.
Mandal R; Chan TA
Cancer Discov; 2016 Jul; 6(7):703-13. PubMed ID: 27107038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
